Search Results - "Shuster, Diana"
-
1
Framework for the Design of Cannabis-Mediated Phase I Drug-Drug Interaction Studies
Published in Current reviews in clinical and experimental pharmacology (2022)“…Cannabis has become legal in much of the United States similar to many other countries, for either recreational or medical use. The use of cannabis products is…”
Get more information
Journal Article -
2
Clinical Pharmacokinetics of Ombitasvir
Published in Clinical pharmacokinetics (01-10-2017)“…Ombitasvir is a potent, nonstructural protein 5A inhibitor of the hepatitis C virus (HCV) that is used in combination with other direct-acting antivirals for…”
Get full text
Journal Article -
3
Drug–Drug Interactions Between the Anti-Hepatitis C Virus 3D Regimen of Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and Eight Commonly Used Medications in Healthy Volunteers
Published in Clinical pharmacokinetics (01-08-2016)“…Background and Aims The three direct-acting antiviral regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir (3D regimen) is approved for treatment of…”
Get full text
Journal Article -
4
Variability in Expression of CYP3A5 in Human Fetal Liver
Published in Drug metabolism and disposition (01-08-2015)“…Members of the cytochrome P450 3A (CYP3A) subfamily of drug metabolizing enzymes exhibit developmental changes in expression in human liver characterized by a…”
Get full text
Journal Article -
5
Identification of CYP3A7 for glyburide metabolism in human fetal livers
Published in Biochemical pharmacology (15-12-2014)“…Glyburide is commonly prescribed for the treatment of gestational diabetes mellitus; however, fetal exposure to glyburide is not well understood and may have…”
Get full text
Journal Article -
6
Effects of chronic kidney disease stage 4, end-stage renal disease, or dialysis on the plasma concentrations of ombitasvir, paritaprevir, ritonavir, and dasabuvir in patients with chronic HCV infection: pharmacokinetic analysis of the phase 3 RUBY-I and RUBY-II trials
Published in European journal of clinical pharmacology (01-02-2019)“…Purpose To characterize the pharmacokinetics of ombitasvir, paritaprevir, ritonavir, dasabuvir, and ribavirin in hepatitis C virus (HCV)-infected patients with…”
Get full text
Journal Article -
7
Pharmacodynamics of Glyburide, Metformin, and Glyburide/Metformin Combination Therapy in the Treatment of Gestational Diabetes Mellitus
Published in Clinical pharmacology and therapeutics (01-06-2020)“…In gestational diabetes mellitus (GDM), women are unable to compensate for the increased insulin resistance during pregnancy. Data are limited regarding the…”
Get full text
Journal Article -
8
Identification of Proline Residues in or near the Transmembrane Helices of the Human Breast Cancer Resistance Protein (BCRP/ABCG2) That Are Important for Transport Activity and Substrate Specificity
Published in Biochemistry (Easton) (20-09-2011)“…The human breast cancer resistance protein (BCRP/ABCG2) confers multidrug resistance and mediates the active efflux of drugs and xenobiotics. BCRP contains one…”
Get full text
Journal Article -
9
Pharmacodynamics of Metformin in Pregnant Women With Gestational Diabetes Mellitus and Nonpregnant Women With Type 2 Diabetes Mellitus
Published in Journal of clinical pharmacology (01-04-2020)“…Gestational diabetes mellitus is a condition similar to type 2 diabetes mellitus (T2DM) in that patients are unable to compensate for the degree of insulin…”
Get full text
Journal Article -
10
Gestational age-dependent changes in gene expression of metabolic enzymes and transporters in pregnant mice
Published in Drug metabolism and disposition (01-02-2013)“…Pregnancy-induced changes in drug pharmacokinetics can be explained by changes in expression of drug-metabolizing enzymes and transporters and/or normal…”
Get full text
Journal Article -
11
Clinical pharmacology and tolerability of REC‐994, a redox‐cycling nitroxide compound, in randomized phase 1 dose‐finding studies
Published in Pharmacology research & perspectives (01-06-2024)“…Cerebral cavernous malformation (CCM) has variable clinical symptoms, including potentially fatal hemorrhagic stroke. Treatment options are very limited,…”
Get full text
Journal Article -
12
Model-Informed Optimization of a Pediatric Clinical Pharmacokinetic Trial of a New Spironolactone Liquid Formulation
Published in Pharmaceutics (08-06-2021)“…Quantitative pharmacology brings important advantages in the design and conduct of pediatric clinical trials. Herein, we demonstrate the application of a…”
Get full text
Journal Article -
13
Maternal-fetal disposition of glyburide in pregnant mice is dependent on gestational age
Published in The Journal of pharmacology and experimental therapeutics (01-08-2014)“…Gestational diabetes mellitus is a major complication of human pregnancy. The oral clearance (CL) of glyburide, an oral antidiabetic drug, increases 2-fold in…”
Get more information
Journal Article -
14
Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir and With or Without Ribavirin for Adolescents With HCV Genotype 1 or 4
Published in Hepatology communications (01-11-2018)“…In adults, treatment of hepatitis C virus (HCV) infection with ombitasvir (OBV)/paritaprevir (PTV)/ritonavir (r) with or without dasabuvir (DSV) and ±ribavirin…”
Get full text
Journal Article -
15
Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or Without Ribavirin in Patients With Kidney Disease
Published in Kidney international reports (01-02-2019)“…Patients with hepatitis C virus (HCV) infection and chronic kidney disease (CKD) are a high-priority population for treatment. We performed a pooled efficacy…”
Get full text
Journal Article -
16
Gestational Age-Dependent Changes in Gene Expression of Metabolic Enzymes and Transporters in Pregnant Mice
Published in Drug metabolism and disposition (01-02-2013)Get full text
Journal Article -
17
Efflux transporters in drug disposition during pregnancy
Published in Drug metabolism and disposition (29-05-2024)“…Evidence-based dose selection of drugs in pregnant women has been lacking due to challenges in studying maternal-fetal pharmacokinetics. Hence, many drugs are…”
Get full text
Journal Article -
18
Pharmacodynamics of metformin in pregnant women with gestational diabetes mellitus and non-pregnant women with type 2 diabetes mellitus
Published in Journal of clinical pharmacology (19-11-2019)“…Gestational diabetes mellitus is a condition similar to type 2 diabetes mellitus (T2DM) in that patients are unable to compensate for the degree of insulin…”
Get full text
Journal Article -
19
Gestational age‐dependent maternal‐fetal glyburide disposition in pregnant mice (1141.5)
Published in The FASEB journal (01-04-2014)“…Glyburide (Gly) is routinely used to treat hyperglycemia during pregnancy. Our objective was to determine if maternal‐fetal disposition of Gly and metabolites…”
Get full text
Journal Article -
20
Identification of Proline Residues In or Near the Transmembrane Helices of the Human Breast Cancer Resistance Protein (BCRP/ABCG2) Important for Transport Activity and Substrate Specificity
Published in Biochemistry (Easton) (26-08-2011)“…The human breast cancer resistance protein (BCRP/ABCG2) confers multidrug resistance and mediates the active efflux of drugs and xenobiotics. BCRP contains one…”
Get full text
Journal Article